Loading...

JAGX - Jaguar Health, Inc.

Penny Signal for 03-25-2024
Penny Stock Signal: JAGX


Loading Chart JAGX

Stock Signal Information


Signal

Penny Stock Signal: JAGX
Report Date: 03-25-2024
Symbol: JAGX - Jaguar Health, Inc.
Sector: Healthcare
Industry: Biotechnology
Penny Stock Signal: JAGX

  JAGX Technical Analysis

Company Contact

Jaguar Health, Inc. (JAGX)
201 Mission St Ste 2375
San Francisco, CALIFORNIA 94105
Phone: 14158965081
Website: http://www.jaguar.health
CEO: Ms. Lisa Conte

JAGX, Jaguar Health, Inc.

JAGX Jaguar Health, Inc. Logo Image

NASDAQ, Nasdaq Capital Market


Company Profile

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The company is headquartered in San Francisco, California and currently employs 17 full-time employees. The firm is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.